UPDATE: Wedbush Initiates Coverage On Achaogen On High Clinical Risk
November 04, 2014 at 09:42 AM EST
In a report published Tuesday, Wedbush analyst Heather Behanna initiated coverage on Achaogen Inc (NASDAQ: AKAO) with a Neutral rating ...